Webinars to the public are an hour in length and are live-streamed on our YouTube Channel. They will also be recorded and available for later viewing below. Our Cohort receives personalised and closed-door Q&A sessions after each public livestream.
The goal of the MedTech Innovator webinars is to provide the medtech ecosystem and our portfolio companies with feedback from experts and professionals in areas that are specific to the strategic needs outlined in our discussions and surveys. Strategic areas to be covered include: intellectual property, product development, commercialization, reimbursement, healthcare economics, regulatory strategy, clinical trial design and execution, and fundraising.
Our webinars are administered virtually and consist of one or more panelists addressing key questions supplied in advance by the MedTech Innovator Accelerator companies, as well as a general discussion on the topic within the context of the evolving healthcare ecosystem.
Stephen is Director of New Ventures and Transactions at Johnson & Johnson Innovation, Asia Pacific. In this role, he is responsible for the deployment of the APIC strategy in Greater China by identifying opportunities (in Pharmaceuticals, Consumer Healthcare and Medical Device) and building networks within the innovation ecosystem. Stephen has over 20 years of experience in the life science sector. Prior to joining Johnson & Johnson, Stephen was the Managing Director of Kybora EM (formerly Torreya EM) where he was responsible for Asia Pacific business development focusing on licensing and M&A advisory services. Stephen is experienced in bringing together investment opportunities and funding. He has been the founder and CEO of CASiGEN Pharma (a Ventac portfolio company) and BioMatrix Dx. He also served as a partner at Ventac Partners where he played a key role in portfolio company building, strategy, marketing, product analysis and IP development. He has also worked as a consultant for 3V SourceOne Capital, Applied Strategies Consulting, First State Investments, and as a patent examiner for the USPTO. Stephen received his D.Phil. in Biochemistry from the University of Oxford, Merton College. He holds an MBA from the University of Chicago Booth School of Business.
Florian leads Strategy and Business Development in Asia Pacific for Siemens Healthineers as well as Marketing & Sales Enablement, focusing his time on strengthening the Asian footprint for the company. He is seeking for new opportunities and partnerships with innovative companies and institutions across the region. Prior to his Asia Pacific role, he held a number of leadership roles in the areas of Marketing, Customer Services, Business Development and Strategy.
Mark began his financial service careers in PwC Canada and has worked in multiple countries in private client services before he moved to the deal’s advisory services. To date, Mark has participated in multiple acquisitions for both corporate and PE investors of deal sizes up to 4 billion USD. He spent a short period of time in China with a bulge private equity firm, focused in technology sector, before he joined Pureland Venture in 2017. He currently is in charge of the Med-Tech Venture Arm, looking for impact investments that can inject value into patient caring system. Mark earned his BBA from University of Toronto, and obtained his CA, CPA licenses in Canada.
Azran Osman-Rani is currently the founder of Naluri Hidup, a digital health technology company providing a cost-effective, accessible digital solution to provide mental health and wellness support, and help users adopt healthier lifestyle behaviour changes.
Osman-Rani is active in the internet technology space as a co-founder and investor to iflix, MoneyMatch, Cognifyx, and YellowPorter. He was previously CEO of iflix in Malaysia and its Group COO – a disruptive internet television video-on-demand service that was launched in Kuala Lumpur in 2015, and now operates across over 30 markets across Asia, Middle East and Africa with 700 employees less than three years from launch.
Previously Osman-Rani was the founding CEO of AirAsia X, the world’s pioneer low-cost longhaul airline. He led the start-up team that developed the business plan, raised capital, secured relevant licenses, and launched AirAsia X’s first flight in November 2007. AirAsia X since expanded from one aircraft to 26, employing over 2,500 staff, and approximately US$1 billion in annual revenue in 2014. Osman-Rani led the development of AirAsia X’s business model that broke many long-haul airline conventions and pioneered various innovations including the 2013-2014 Skytrax World’s Best Low-Cost Airline Business Class flatbed seats, Quiet Zone, Fly-Thru connections, Seat assignments and upgrade options, and In-flight entertainment services.
Prior to AirAsia X, Azran Osman-Rani was formerly the Senior Director of Business Development for Astro All Asia Networks plc, where he led the start-up and business building of Astro’s media, creative content, and technology investments and joint ventures across Southeast Asia, India and Greater China.
Joseph is the Managing Partner of Verge HealthTech Fund focusing on early stage healthcare technology companies relevant to emerging markets. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 20 healthcare technology companies to date. Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.
Medtech R&D with 25+ years experience in leading R&D organizations, technology and innovation stApzc and Globalrategies with Ip management n strategic partnerships. Passiobatedriver of Digital health technologies and business model innovations. Leadership roles in R&D at JnJ and Boston Scientific across 10+ disease platforms, business units and more than 15+ product launches and 50+ patents delivered by high performance teams. Currently leading J&J Vision APAC R&D and collaboration with Singapore Eye Research Institute.
Yan Lin is an experienced business development professional specializing in the development of medical technologies for both mature markets and developing world applications. She has found success building businesses in the US, Europe and APAC markets.
As the first local hire in the Singapore office, she built Cambridge Consultants’ medtech business in APAC over the course of 5 years. Prior experiences includes developing next generation DNA sequencing technology, molecular diagnostics, and immunoassays.
With her knowledge on regulatory, reimbursement, competitive landscapes, and product development, Yan Lin is a strategic advisor on commercial and product development strategy. Graduated top of her biomedical engineering class from the University of Southern California. Graduated Masters of Bioscience Enterprise from Cambridge University
Santosh is a Senior Principal Engineer at Oliver Healthcare Packaging, Singapore and is responsible for technical services support for customers within the Asia-Pacific region. He has over 18 years of experience in packaging development, quality assurance, packaging
engineering, new packaging development and technical service. Santosh worked at Edwards Lifesciences and Zimmer Biomet as a packaging engineer, focused on higher-end class III device applications. A portion of his career was also in flexible film development, converting and lamination.
Santosh graduated from Michigan State University, with a Masters in Packaging Science, as well as a Bachelors degree in Chemistry and a Diploma in Packaging Technology from Mumbai University. Santosh is a trained auditor for ISO13485.
|JUL 14||1 – Perfecting Your Pitch Video|
|JUL 21||2 – Strategic Partnerships & Working with Multinationals|
|JUL 28||3 – Fund Raising & Deal Structuring|
|AUG 4||4 – Product Design & Development|
|AUG 12||5 – Manufacturing & Supply Chain Management: Avoiding Pitfalls|
|AUG 25||6 – Clinical Trial Management & Working with CROs|
|SEPT 1||7 – Regulatory Pathways: US versus APAC|
|SEPT 8||8 – Health Economics & Working with Payers: US versus APAC|
|SEPT 15||9 – Cybersecurity & Data Privacy|
|SEPT 22||10 – Commercialization: Managing KOL Networks, Sales & Distribution|